Allergan Completes Acquisition of Oculeve

According to an announcement from FDAnews.com, “Allergan said Monday that it has completed its $125 million purchase of San Francisco-based dry eye disease devicemaker Oculeve.”  For more information on this acquisition, please visit:...

FDA Launches Open-Source Platform for Precision Medicine

According to MedCityNews.com, ” It’s called precisionFDA, and will be the newest cog in the White House’s Precision Medicine Initiative.  It’s planned for beta release in December this year, and is being developed by Bay Area startup DNAnexus. In a blog,...